The Doctor Other Doctors Train With
International KOL & trainer for 14+ device brandsTrained 500+ doctors across AsiaMBBS (NUS) · MRCS (Edinburgh) · Dual UK Masters with DistinctionEvery treatment personally performed — never delegated
Dr Sin Yong · MBBS (NUS) · MRCS (Edin) · MSc Aesthetic Medicine (London) · MSc Practical Dermatology (Cardiff) · International KOL
Most hair loss treatment stops at slowing the loss. Regenerative hair restoration aims further: reactivating follicles that have miniaturised but not died. Dr Sin Yong's protocols combine Regenera Activa autologous micrografts, the 1540 nm laser stimulation he published in PRIME Journal, and medical therapy — sequenced by your hair loss stage, for men and women.
Androgenetic hair loss is progressive miniaturisation: follicles shrink over cycles, producing finer, shorter hairs before they stop producing at all. The clinical window that matters is the years when follicles are miniaturised but alive — that is when regenerative stimulation can still change their behaviour. Once a zone is genuinely bald and shiny, follicles are gone, and transplantation becomes the honest conversation instead. Staging — Norwood for men, Ludwig for women — is therefore the first step, not a formality.
No single tool treats hair loss well. Here the programme combines three arms: Regenera Activa — autologous micrografts from your own scalp, processed and delivered to thinning zones to supply regenerative cells; laser hair stimulation (H2LT) — including the 1540 nm non-ablative protocol Dr Sin Yong published in PRIME Journal; and medical therapy where indicated. Adjuncts such as polynucleotides or topical exosomes support, but never replace, these arms.
The three arms act on the follicle differently. Autologous micrografting (Regenera Activa) harvests millimetre punch grafts from your own occipital scalp — the zone genetically resistant to androgenetic loss — mechanically processes them into a cell-rich suspension, and delivers it into thinning areas, supplying progenitor cells and signalling factors to follicles that are miniaturising. Laser stimulation works photothermally: fractional non-ablative energy delivered to the scalp is followed by upregulation of the proteins involved in hair synthesis, with angiogenesis — new microvascular supply — a postulated pathway. Medical therapy addresses the androgen driver itself, which is why it remains the background of most male protocols.
Dr Sin Yong's 1540 nm erbium-glass protocol for androgenetic alopecia was published in PRIME Journal (Nov/Dec 2023) — a case-based account of fractional laser hair stimulation in a patient unsuitable for standard oral therapy. It reflects the wider point of this page: regeneration is a protocol you design per patient — stage, sex, donor quality, tolerance for medication — not a machine you book.
Scalp examination and trichoscopy establish your stage (Norwood or Ludwig), miniaturisation pattern and donor integrity — the numbers the whole plan is built on.
Autologous micrografts from your own scalp, processed chairside and delivered to thinning zones — regenerative cells from you, for you. See Regenera Activa.
Fractional laser scalp stimulation — including the 1540 nm protocol Dr Sin Yong published in PRIME Journal — for patients averse or unsuited to long-term medication. See H2LT.
The androgen pathway is treated medically where appropriate — discussed honestly, including who should not take it. Regeneration works best on a treated scalp.
Diffuse female thinning is staged and treated on its own logic — hormonal work-up included. See female hair loss.
Polynucleotides and topical exosomes can support the protocol. They are adjuncts — never sold here as standalone cures.
“A miniaturised follicle can be woken. A dead one cannot. The whole discipline of hair regeneration is knowing which one you are looking at.”Dr Sin Yong
References: Secret 1540 nm Erbium Glass Laser Treatment for Hair Regrowth in Androgenetic Alopecia (Sin Yong, PRIME Journal, Nov/Dec 2023, p.46) · Male Pattern Baldness: Classification and Incidence (Norwood, 1975) · Classification of the Types of Androgenetic Alopecia (Common Baldness) Occurring in the Female Sex (Ludwig, 1977)
History, examination, trichoscopic staging and — for women — screening for non-androgenetic drivers. You are told plainly whether regeneration, medication, or a transplant conversation fits your stage.
The arms are sequenced for your case: micrografts, laser stimulation, medical therapy and any adjuncts, with the reasoning explained before anything is booked.
Regenera micrografting and laser sessions are performed personally by Dr Sin Yong — the doctor who designed the protocol does the procedure.
Progress is reviewed against baseline trichoscopy and standardised photographs — the same way it would be measured in a study, because that is where the protocols come from.
A programme aimed at reactivating miniaturised-but-living follicles rather than only slowing loss: autologous micrografts (Regenera Activa) supply regenerative cells, fractional laser stimulates follicle activity, and medical therapy addresses the androgen driver. The arms are sequenced by your stage.
A transplant relocates follicles into zones that are already bald; regeneration stimulates follicles that still exist but are miniaturising. They answer different stages — and an honest assessment tells you which conversation you are actually in.
Millimetre-scale punch grafts are taken from the back of your own scalp — the zone resistant to androgenetic loss — processed chairside into a cell-rich suspension, and delivered into thinning areas in the same session. It is autologous: nothing is used but your own tissue.
Fractional laser stimulation has a growing literature, and Dr Sin Yong published his 1540 nm erbium-glass protocol for androgenetic alopecia in PRIME Journal (2023). It is a genuine option — particularly for patients unsuited to long-term medication — within a staged protocol, not a magic wand.
That is a staging question. If your thinning zones still show miniaturised hairs on trichoscopy, the window is open. If a zone is smooth and shiny, follicles there are gone and regeneration cannot recreate them — you will be told so directly.
Yes — female pattern loss (Ludwig staging) is a core indication, and diffuse female thinning often responds well to the micrograft-plus-stimulation approach. Women are also screened for thyroid, iron and hormonal drivers before any protocol starts.
Often, yes — regeneration works best on a scalp where the androgen driver is controlled, and medication remains the evidence-backed background for most male protocols. Who should and should not take it is discussed honestly, and laser-led protocols exist for those who cannot.
Platelet-rich plasma is a recognised regenerative adjunct. Where it fits a case it can be incorporated — but in this practice the core regenerative arm is autologous micrografting, which delivers cellular material rather than plasma alone.
The donor site is anaesthetised for the punch harvest; most patients describe pressure rather than pain, and normal activity typically resumes the next day. Specifics for your case are covered at consultation.
Hair operates in months, not weeks — follicle cycles are long, and reviews are scheduled around trichoscopic reassessment rather than daily mirror checks. Timelines for your stage are set honestly at assessment.
No. Topical exosomes and polynucleotide injections can support a protocol, but the evidence does not support them as standalone cures — and this page will not sell them to you as one.
It depends on which arms your protocol uses and over what period. Costs are set out transparently at consultation — numbers quoted before staging would be meaningless.
Start with a message, not an appointment. Describe your hair loss — how long, which areas, family pattern — on WhatsApp and you will get a straightforward reply about whether an assessment makes sense.
WhatsApp +65 8023 7170This page is general information, not a diagnosis. Suitability for any treatment is decided at an in-person medical assessment.